A significant and progressive decline in blood levels of omega-3 DHA transporter MFSD2a may be a biomarker of Alzheimer's disease

1

A significant and progressive decline in blood levels of omega-3 DHA transporter MFSD2a may be a biomarker of Alzheimer's disease alzheimer's blood-brain barrier brain dementia omega-3 mdpi.com
submitted about 1 year ago by dan

view 1 comment | tweet this

0

From the publication:

The aim of this study was to investigate the expression of MFSD2a in the whole blood and brain as a potential biomarker of Alzheimer’s disease (AD). […] We found a significant and progressive decline of MFSD2a levels in blood of AD patients. We also corroborated a significant reduction of DHA and other n-3 long-chain polyunsaturated FA in serum of AD.

You must first login , or register before you can comment.

emphasized text	surround text with `asterisks`
strong text	surround text with `two asterisks`
~~struck-through~~	surround text with `~~two tilde characters~~`
linked text	`[linked text](http://example.com/)` or just a bare URL to create without a title
quoted text	prefix text with `>`
pre text	prefix text with at least `4 spaces`

* Name
* Email
* Message
* All three fields are required.

Subscribe to the Channel

Like FMF on Facebook

Love FMF on Twitter

Top News

Navigation